Detalhe da pesquisa
1.
Prognostic factors and outcome of patients with hematological malignancies in phase I trials: the Gustave Roussy scoring system.
Anticancer Drugs
; 28(5): 540-545, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28225458
2.
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.
Cancer Discov
; 7(6): 586-595, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28365644
3.
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01).
Eur J Cancer
; 59: 79-89, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27017289
4.
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.
Clin Cancer Res
; 22(12): 2960-8, 2016 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26758560
5.
From Uniplex to Multiplex Molecular Profiling in Advanced Non-Small Cell Lung Carcinoma.
Cancer J
; 21(5): 413-24, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26389767
6.
Targeting FGFR Signaling in Cancer.
Clin Cancer Res
; 21(12): 2684-94, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26078430
7.
Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer.
Eur J Cancer
; 51(14): 1946-52, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26208462
8.
Incorporating immune-checkpoint inhibitors into systemic therapy of NSCLC.
J Thorac Oncol
; 9(2): 144-53, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24419410
9.
[Immune-checkpoints: the new anti-cancer immunotherapies]. / Immune-Checkpoints: les nouvelles immunothérapies anticancéreuses.
Bull Cancer
; 100(6): 601-10, 2013 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-23735730
10.
Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon?
Lung Cancer
; 70(2): 221-2, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20828859